PKPatrycja Karnas-Bogacka

Patrycja Karnas-Bogacka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Patrycja Karnas-Bogacka has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of guidelines for diabetes diagnostics in 2019 and 2024 in Poland and the rights of insured persons to health services, including access to psychological care

    by Monika Kamińska, Magdalena Miernik-Skrzypczak, Marta Malicka, Patrycja Karnas-Bogacka, Katarzyna Moczyróg, Katarzyna Barwinek-Grajek, Aleksandra Błaszczyk

    This article compares diabetes diagnostics and treatment reimbursement in Poland between 2019 and 2024, highlighting the changes that occurred over these years. The review is based on an analysis of literature covering diabetes classification, diagnosis, complications, and current guidelines. Scientific articles, reviews, and relevant legislation were analyzed. Diagnostic guidelines highlight the use of glycated haemoglobin (HbA1c) and recommend genetic testing for neonatal diabetes. Reimbursements for diabetes treatment, particularly for modern devices and insulin pen needles, have improved. The 2024 guidelines highlight the importance of mental health, recommending regular psychological assessments. Guidelines have become more comprehensive, and reimbursement policies are more extensive, making access to essential therapies easier for patients. These changes aim at improving treatment outcomes and enhancing the quality of life.

  • Open Access

    Pharmacotherapy for Alcohol Use Disorder: Enhancing Health and Treatment Outcomes

    by Katarzyna Moczyróg, Aleksandra Sierpińska, Agata Jaksz, Maria Jasiewicz, Patrycja Karnas-Bogacka, Marta Malicka, Aleksandra Kozioł, Piotr Mól

    Introduction and Objective: Alcohol Use Disorder (AUD) combines alcohol abuse and dependence into a single condition characterized by an inability to control alcohol consumption despite its negative consequences. Treatment for AUD includes both pharmacological and behavioral therapies aimed at achieving complete abstinence. This paper reviews pharmacological treatment options and their clinical effectiveness. Given the increasing prevalence of AUD globally, including in Poland, understanding the availability, efficacy, and cost of these treatments is essential to improve patient outcomes. Review methods: This review analyzes current literature on pharmacological treatments for AUD, including medications approved by FDA and EMA. Sources include peer-reviewed articles and clinical trials. Results: Naltrexone and nalmefene have been shown to be effective in reducing alcohol consumption and cravings, while acamprosate and topiramate are particularly effective in relapse prevention and maintaining abstinence. Gabapentin is effective in treating alcohol withdrawal symptoms, while baclofen, mifepristone, and N-acetylcysteine show promising results but require further research. Ondansetron has been documented as effective in treating young patients with early-onset AUD, and varenicline effectively reduces alcohol cravings in individuals with nicotine dependence. The disulfiram implant is ineffective in treating alcohol dependence and maintaining abstinence, with its action primarily based on the fear of a disulfiram reaction. Conclusions: Pharmacological treatments for AUD, combined with behavioral therapy, help reduce alcohol consumption or maintain abstinence. Individualized therapy selection is crucial, taking into account the patient's health status and the presence of other conditions. Further research is required to optimize treatment, both in terms of pharmacological mechanisms and better tailoring the therapy to the specific needs of individual patients.

  • Open Access

    Acne Vulgaris Management: A Review of First-Line and Advanced Pharmacological Treatments

    by Krzysztof Dobrzeniecki, Anna Zygmunt, Karolina Karoń, Łukasz Karoń, Patrycja Karnas-Bogacka

    Introduction and objective: Acne vulgaris is a common chronic inflammatory skin disease affecting hair and sebaceous follicles, characterized by skin lesions most commonly appearing on the face. Several factors predispose individuals to the development of acne, including hormonal imbalances, genetic predisposition, and the use of certain medications. This review aims to evaluate and summarize first-line and advanced pharmacological treatments for acne vulgaris, highlighting their efficacy, safety, and emerging therapies for optimal management. Review methods: The literature review utilized databases covering sources from PubMed, Google Scholar, Scopus, and Web of Science using the search terms encompassing the following keywords: ‘acne vulgaris’ and ‘topical retinoid therapy’, ‘benzoyl peroxide’, ‘azelaic acid’, ‘topical antibiotics’, ‘oral antibiotics’, ‘contraceptive agents’, ‘antiandrogen therapy’, ‘isotretinoin’. Brief description of the state of knowledge: Current treatment methods range from topical therapies (i.e. antibiotics and retinoids) for mild cases to systemic medications (i.e. antibiotics, retinoids, and hormonal) for moderate to severe acne. In most cases, treatment should start with topical therapy. Summary: Early intervention is crucial to mitigate the risk of scarring and psychosocial consequences. Emerging therapeutic strategies have the potential to enhance treatment outcomes.


  • Open Access

    Vitamin D Supplementation in Selected Autoimmune Diseases

    by Monika Kamińska, Aleksandra Kozioł, Magdalena Agata Miernik-Skrzypczak, Natalia Dąbrowska, Adrian Uchto, Patrycja Karnas-Bogacka, Marta Katarzyna Malicka, Maria Jasiewicz, Katarzyna Moczyróg

    Introduction and Objective. In recent years, awareness of the problem of vitamin D deficiency in the human body has been steadily increasing. There is a growing emphasis on investigating the effects of vitamin D supplementation both in the prevention of autoimmune diseases and in the course of existing diseases. The aim of this study is to highlight and discuss the role of vitamin D supplementation in selected autoimmune diseases.Review methods. The publication is a narrative review. The PubMed electronic database was used to review the literature. To ensure the highest substantive value, the focus was mainly on studies from the last 8 years, with only 6 studies published before 2016, concerning autoimmune diseases.Results. There are still lots of unknowns when it comes to physiology and the role that vitamin D plays in our body and deepening the knowledge of its functions would definitely help prevent many diseases concerning various systems such as musculoskeletal, immune and nervous systems. Wide range of studies have already proven that appropriate supplementation of vitamin D prevents complications and exacerbations of disorders like rheumatoid arthritis, Hashimoto’s thyroiditis, ulcerative colitis, type 1 diabetes and multiple sclerosis. Unfortunately there is no unambiguous evidence of noticeable improvement in the patients suffering from psoriasis after taking vitamin D. There is a huge need for developing guidelines which would establish specific supplementation protocols considering various factors since it is inexplicably difficult to obtain an optimal level of vitamin D in our body.Summary. The increasing prevalence of autoimmune diseases in the population, their coexistence with vitamin D deficiency, and the scientifically proven impact of this vitamin on the body imply the need for an in-depth analysis of the relationship between its supplementation and the prevention and modification of the course of autoimmune diseases.

  • Open Access

    Quality of Life in Primary Biliary Cholangitis - Advances in the Treatment

    by Agnieszka Kuzio, Aleksandra Cieplińska, Grzegorz Jama, Kinga Ziojła-Lisowska, Marzena Pliszka, Zuzanna Piasecka, Karolina Haczkur-Pawłowska, Maciej Borowiak, Patrycja Kolano, Patrycja Karnas-Bogacka

    Primary sclerosing cholangitis (PSC) is an inflammatory, cholestatic and progressively fibrotic liver disease devoid of effective medical intervention. PBC is a presumed immune-mediated liver disease of middle-aged women associated with significant morbidity and mortality. People living with PBC are frequently symptomatic, experiencing a quality-of-life burden dominated by fatigue, itch, abdominal pain, and sicca complex. Many drugs have been studied for treatment, including agents with choleretic and immunosuppressive properties. Future PBC licensed therapy will likely include peroxisome proliferator activated receptor (PPAR) pathway agonists, including specific PPAR-delta agonism (seladelpar), as well as elafibrinor and saroglitazar (both with broader PPAR agonism). Effective therapy reduces the need for transplantation and improves life expectancy.


  • Open Access

    The Impact of Nutritional and Dietary Factors on Hashimoto's Thyroiditis: A Comprehensive Review

    by Zuzanna Rybka, Monika Kamińska, Katarzyna Moczyróg, Patrycja Karnas-Bogacka, Adrian Uchto, Natalia Dąbrowska, Kaja Marszałek-Moc, Magdalena Miernik-Skrzypczak, Maria Jasiewicz, Karolina Alicja Palacz

    Introduction. Hashimoto's disease (HD) is the main cause of hypothyroidism in countries where there is no iodine deficiency in the diet. Characteristic antibodies for it are anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg) and their level positively correlates with the severity of HD. Whereas its occurrence is related to genetic, environmental and existential factors. Aim of study. The aim of this study was to analyze dietary factors (protein, fat, vitamin D, iodine, selenium, gluten) and intestinal microbiota on the risk of developing Hashimoto's disease and the influence of each of these factors on its course. Materials and methods. More than 90 articles addressing these issues were analyzed. They were found using the PubMed search engine, and the time frame of these publications covered the last 10 years. Results. Excess iodine is the most important environmental factor influencing the development of Hashimoto's disease. Also, selenium deficiency contributes to the development of HD. On the other hand, the concentration of vitamin D is lower in patients with Hashimoto's disease than in the general population. Furthermore, Vitamin D supplementation reduces the concentration of anti-Tg antibodies. In addition, different types of dietary fat affect thyroid hormone levels differently and a deficiency of protein in the diet causes an increase in TSH and a decrease in thyroid hormones. Moreover, changes in the gut microbiome have been observed in people suffering from Hashimoto's disease. Conclusions. The risk of developing Hashimoto's disease can be increased and decreased by diet and diet allows for the modification of hormone levels in the hypothalamus-pituitary-thyroid axis.


  • Open Access

    Retrospective Analysis of Reasons for Presenting to Emergency Ophthalmic Care in Poland and the USA – Literature Review

    by Aneta Michalczewska, Kaja Marszałek-Moc, Karolina Alicja Palacz, Magdalena Miernik-Skrzypczak, Maria Jasiewicz, Monika Kamińska, Patrycja Karnas-Bognacka, Natalia Dąbrowska

    Introduction. Emergency Department is a hospital unit, where is provided care in in cases of sudden threat to life and health. One of the reasons why patients come to the Emergency Department is eye damage. Emergency ophthalmological services are a very important form of ophthalmological care because some conditions and diseases require quick intervention to prevent permanent vision damage or eye loss. Patients come to hospital emergency departments for many reasons, such as: eyeball injury, sudden pain or unexpected deterioration of vision. It is worth noting that some patients do not understand the provision of services within health care units and in conditions that do not require urgent care, they seek it in emergency rooms. Aim of study. The following study analyzes the reasons for reporting to emergency ophthalmological services in Poland and the United States. Knowing the most common causes of patients' ailments and the factors that influence them, we can plan strategies for providing specific services within health care units. Materials and methods. The work reviews articles published in the years 2005-2023 in Poland and the United States of America. The results obtained from individual studies were divided in terms of age, gender, traumatic and non-traumatic causes. Additionally, it was checked how often patients had to be hospitalized after staying in Polish emergency departments. Conclusions. Injuries and other eye diseases affect patients regardless of gender and age. Most often, these are adult men.